| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 03/13/1996 | EP0700906A1 Heterocyclic derivatives of N-phenylamides |
| 03/13/1996 | EP0700438A1 Opioid receptors: compositions and methods |
| 03/13/1996 | EP0700291A1 15-substituted 4-azasteroids |
| 03/12/1996 | US5498729 Prodrug compositions |
| 03/07/1996 | WO1996006635A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 03/07/1996 | CA2198721A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 03/06/1996 | CN1117874A Nasally administrable compositions |
| 03/05/1996 | US5496826 Pharmaceutical methods of using heterocyclic derivatives of N-phenylamides |
| 03/05/1996 | US5496556 Administering a steroid reductase inhibiting compound, an androstene derivative |
| 03/03/1996 | CA2156753A1 Heterocyclic derivatives of n-phenylamides |
| 02/28/1996 | EP0698109A1 Gene transfer into pancreatic and biliary epithelial cells |
| 02/27/1996 | US5494929 Administering to humans |
| 02/27/1996 | US5494914 Useful for treatment of diseases whose progress is aided by activation of androgen receptors |
| 02/27/1996 | US5494907 11-β substituted-19-nor steroids |
| 02/27/1996 | US5494806 A genetic engineered, hybridized probe consisting of an 18-polynucleotides sequence |
| 02/22/1996 | WO1996005544A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 02/22/1996 | WO1996005217A1 Pharmaceutical compositions containing estra-1,3,5(10)-triene derivatives |
| 02/22/1996 | WO1996005216A1 Estra-1,3,5(10)-triene derivatives, methods of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | WO1996005177A1 Novel pyrimidine derivatives and processes for the preparation thereof |
| 02/22/1996 | CA2197195A1 Current-to-pressure transducer with selectable, adjustable input filter |
| 02/22/1996 | CA2196694A1 Estra-1,3,5(10)-triene derivatives, process of preparing such compounds and pharmaceutical compositions containing them |
| 02/22/1996 | CA2196678A1 Pharmaceutical preparations containing estra-1,3,5(10)-triene derivatives |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1117050A 14 alpha, 17 alpha-ethano-16 alpha-hydroxy-estratriene |
| 02/21/1996 | CN1031061C Process for preparing of 14 alpha, 17 alpha-ethano-16 alph-hydroxy-estratriene derivatives |
| 02/20/1996 | US5492922 Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation |
| 02/20/1996 | US5492908 Antiarthritic |
| 02/15/1996 | DE4429398A1 Pharmazeutische Zusammensetzungen mit Estra-1,3,5(10)-trien-Derivaten Pharmaceutical compositions with Estra-1,3,5 (10) -triene derivatives |
| 02/15/1996 | DE4429397A1 Estra-1,3,5(10)-trien-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 02/14/1996 | EP0696275A1 Vitamin d amide derivatives |
| 02/14/1996 | CN1116823A Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 02/14/1996 | CN1116629A Monomeric insulin analog formulations |
| 02/08/1996 | WO1996003138A1 Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
| 02/07/1996 | EP0695309A1 Oxytocin antagonist |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 01/31/1996 | EP0694561A1 Calcitonin analogue and use thereof |
| 01/31/1996 | EP0694039A1 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |
| 01/31/1996 | EP0693922A1 Pharmaceutical composition containing lipophilic drugs |
| 01/31/1996 | EP0423322B1 Grf analogs viia |
| 01/30/1996 | US5488058 Urogenital disorders or osteoporosis |
| 01/24/1996 | CN1115252A Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 01/24/1996 | CN1115242A Chinese drug for prevention of mammary gland hyperplasia |
| 01/18/1996 | WO1996001275A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | CA2193399A1 O-glycosylated authentic igf-i and truncated variants thereof, a method of preparation thereof and pharmaceutical compositions |
| 01/17/1996 | EP0692489A1 Preparation of stable zinc insulin analog crystals |
| 01/17/1996 | EP0515544B1 Steroid sulphatase inhibitors |
| 01/17/1996 | CN1114903A A styrene-isoprene-styrene copolymer-based transdermal matrix system for the administration of an oestrogen and/or a progestogen |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0394429B1 Preparation for transdermal application containing gestodene |
| 01/10/1996 | CN1114587A EVA-based transdermal matrix system for the administration of an oestrogen and/or progestogen |
| 01/03/1996 | EP0689458A1 Active-substance patch for releasing estradiol to the skin |
| 01/03/1996 | EP0689428A1 Enhanced circulation effector composition and method |
| 12/28/1995 | WO1995035116A1 Hgh containing pharmaceutical compositions |
| 12/28/1995 | WO1995027495A3 Treatment of partial growth hormone insensitivity syndrome |
| 12/27/1995 | EP0688565A1 Tablet, capsule, or granule comprising desogestrel |
| 12/26/1995 | US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them |
| 12/26/1995 | US5478852 Administering |
| 12/21/1995 | WO1995034563A1 Pyrazolo and pyrrolopyridines |
| 12/21/1995 | WO1995034561A1 Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 12/21/1995 | WO1995034555A1 Benzimidazolone derivatives with central dopaminergic activity |
| 12/21/1995 | WO1995034540A1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators |
| 12/21/1995 | WO1995034534A1 Enzyme inhibitors |
| 12/21/1995 | CA2192668A1 Amidino sulfone derivatives for use as inos inhibitors claims |
| 12/21/1995 | CA2190611A1 Covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives |
| 12/20/1995 | EP0290496B2 Use of an adenosine, hypoxanthine and ribose-containing solution for improved protection of the heart during surgery |
| 12/14/1995 | WO1995033750A1 Corticotropin releasing factor antagonists |
| 12/13/1995 | EP0686037A1 Hormone replacement therapy |
| 12/12/1995 | US5474978 Insulin analog formulations |
| 12/12/1995 | US5474771 Inhibits T cell activation of B cells ; binds to epitope |
| 12/07/1995 | WO1995032988A1 Novel parasite protease genes and proteins |
| 12/07/1995 | CA2189741A1 Novel parasite protease genes and proteins |
| 12/06/1995 | EP0684825A1 Method of preventing or inhibiting fertilization |
| 12/06/1995 | EP0445255B1 Treatment of conditions and disease |
| 12/05/1995 | US5472962 Antiestrogenic agents |
| 11/29/1995 | CN1112421A Estradiol weekly-acting percutaneous absorption adhesive plaster |
| 11/29/1995 | CN1112420A Orally administerable pharmaceutical formulations |
| 11/28/1995 | US5470826 Single chain proteins with FHS suppressing activity isolated from follicular fluid and uses thereof |
| 11/28/1995 | CA1337660C Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives |
| 11/22/1995 | EP0682878A2 Nutrition |
| 11/22/1995 | EP0682654A1 Benzo-fused lactams promote release of growth hormone |
| 11/21/1995 | US5468736 Hormone replacement therapy |
| 11/21/1995 | CA1337591C Therapeutic composition comprising oestrogen and antioestrogen |
| 11/15/1995 | EP0681833A2 Nasally administrable compositions |
| 11/15/1995 | CN1030255C Ring groth hormone releasing factor (GRF), analogue and its process |
| 11/14/1995 | US5466698 Substituted tetrahydrophyridines and hydroxypiperidines as central nervous system agents |
| 11/09/1995 | WO1995029900A1 CONDENSED HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE AS GnRH ANTAGONISTS |
| 11/09/1995 | CA2189053A1 Condensed heterocyclic compounds, their production and use as gnrh antagonists |
| 11/08/1995 | EP0680327A1 Therapeutic uses and delivery systems of dehydroepiandrosterone |
| 11/08/1995 | EP0412149B1 Use of il-7 in providing medications for stimulation of platelet production |
| 11/07/1995 | US5464847 Moduators of corticotropin releasing factor |
| 10/26/1995 | WO1995028405A1 Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
| 10/26/1995 | CA2186124A1 Bicyclic thiophene derivatives and use as gonadotropin releasing hormone antagonists |
| 10/25/1995 | EP0678018A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 10/24/1995 | US5461175 Method for separating enantiomers of aryloxipropanolamine derivatives, and chiral solid-phase chromatography material for use in the method |
| 10/24/1995 | US5461031 Monomeric insulin analog formulations |
| 10/24/1995 | US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women |
| 10/19/1995 | WO1995027495A2 Treatment of partial growth hormone insensitivity syndrome |